White Mark Andrew bought RCKT
February 16, 2024 · Form 4 insider transaction
White Mark Andrew bought 32,727 shares of Rocket Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
32,727
Price
$0.00
Total value
N/A
InsiderWhite Mark Andrew
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 16, 2024
Filing dateFebruary 21, 2024
Shares owned after32,727
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents a right to purchase a total of 32,727 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.